Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
(NASDAQ:MESO) NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it h...
How will the potential repayment of secured debt improve MESO's balance sheet and credit profile, and what impact might this have on the company's financing flexibility and valuation?
What are the terms (interest rate, conversion price, maturity) of the convertible notes and how do they compare to the company's existing debt structure?
How will the issuance of up to $50 million in convertible notes affect MESO's dilution and share price dynamics?
5 days ago